CALGB 80405 - A Phase III Trial Of Irinotecan/5-Fu/Leucovorin or Oxaliplatin/5-Fu/Leucovorin With Bevacizumab, Or Cetuximab (C225), or With the Combination of Bevacizumab And Cetuximab For Patients with Untreated Metastatic Adenocarcinoma of The Colon Or Rectum
GCC 0319 - A Phase II Study of Low-Dose Upper Abdominal Radiation Therapy (UART) as a Chemosensitizer in Patients with Locally Advanced or Metastatic Pancreatic Tumors
GCC 0740 - Neoadjuvant Paclitaxel Poliglumex (PPX; CT-2103), Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI: X64001) IND # 77,499.
GCC0808 - A Randomized Double-Blind Phase III Study of RAD001 10MG/D Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Neuroendocrine Tumor
GCC0905 - Phase 1/2a, Dose-Escalation, Safety, Pharmacokinetic, and Preliminary Efficacy Study of Intratumoral Administration of DTA-H19 in Patients with Unresectable Pancreatic Cancer
RTOG 0822 - A Phase II Evaluation of Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy (IMRT) In Combination with Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer
Email this Page
Print this Page
